Galectin Therapeutics
GALT
#8075
Rank
$0.17 B
Marketcap
$2.75
Share price
1.48%
Change (1 day)
43.23%
Change (1 year)

Market capitalization of Galectin Therapeutics (GALT)

Market cap: $0.17 Billion

As of September 2024 Galectin Therapeutics has a market cap of $0.17 Billion. This makes Galectin Therapeutics the world's 8075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galectin Therapeutics from 2002 to 2024

End of year Market Cap

Year Market cap Change
2024$0.17 B66.81%
2023$0.10 B52.89%
2022$67.15 M-45.33%
2021$0.12 B-3.92%
2020$0.12 B-21.43%
2019$0.16 B15.17%
2018$0.14 B18.69%
2017$0.11 B277.16%
2016$31.56 M-33.24%
2015$47.27 M-38.85%
2014$77.3 M-47.97%
2013$0.14 B351.23%
2012$32.92 M-55.49%
2011$73.97 M28.62%
2010$57.51 M297.01%
2009$14.48 M235.73%
2008$4.31 M-84.73%
2007$28.25 M93.09%
2006$14.63 M-82.44%
2005$83.31 M22%
2004$68.28 M-28.2%
2003$95.11 M72.31%
2002$55.2 M

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of Galectin Therapeutics was reported to be:

$0.16 Billion
by Yahoo Finance info icon info icon
$0.16 Billion
by CompaniesMarketCap info icon info icon
$0.16 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$4.11 B 2,304.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.72 B 909.97%๐Ÿ‡บ๐Ÿ‡ธ USA